NDC 0944-2844

RECOMBINATE

Antihemophilic Factor Recombinant

RECOMBINATE is a Kit in the Plasma Derivative category. It is labeled and distributed by Baxalta Us Inc.. The primary component is .

Product ID0944-2844_74f3de5a-1800-4125-9181-0497bb20269c
NDC0944-2844
Product TypePlasma Derivative
Proprietary NameRECOMBINATE
Generic NameAntihemophilic Factor Recombinant
Dosage FormKit
Marketing Start Date2010-03-15
Marketing CategoryBLA / BLA
Application NumberBLA103375
Labeler NameBaxalta US Inc.
Active Ingredient Strength0
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 0944-2844-10

1 KIT in 1 CARTON (0944-2844-10) * 10 mL in 1 VIAL, GLASS (0944-2834-01) * 5 mL in 1 VIAL, GLASS (52919-003-08)
Marketing Start Date2010-03-15
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0944-2844-10 [00944284410]

RECOMBINATE KIT
Marketing CategoryBLA
Application NumberBLA103375
Product TypePLASMA DERIVATIVE
Billing UnitEA
Marketing Start Date2010-03-15

Drug Details

NDC Crossover Matching brand name "RECOMBINATE" or generic name "Antihemophilic Factor Recombinant"

NDCBrand NameGeneric Name
0944-2831RecombinateAntihemophilic Factor Recombinant
0944-2832RecombinateAntihemophilic Factor Recombinant
0944-2833RecombinateAntihemophilic Factor Recombinant
0944-2841RECOMBINATEantihemophilic factor recombinant
0944-2842RECOMBINATEantihemophilic factor recombinant
0944-2843RECOMBINATEantihemophilic factor recombinant
0944-2844RECOMBINATEantihemophilic factor recombinant
0944-2845RECOMBINATEantihemophilic factor recombinant

Trademark Results [RECOMBINATE]

Mark Image

Registration | Serial
Company
Trademark
Application Date
RECOMBINATE
RECOMBINATE
97043921 not registered Live/Pending
Baxalta Incorporated
2021-09-24
RECOMBINATE
RECOMBINATE
74229857 not registered Dead/Abandoned
Baxter International Inc.
1991-12-12
RECOMBINATE
RECOMBINATE
73796939 not registered Dead/Abandoned
BAXTER INTERNATIONAL INC.
1989-05-01

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.